PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8910474-6	1996	Fas-induced apoptosis was completely inhibited by butyrolactone I, a specific inhibitor of Cdc2 kinase.	butyrolactone I	50-65	cyclin dependent kinase 1	Homo sapiens	91-95	
9371520-6	1997	Consistent with this, Thr14/Tyr15 phosphorylation was induced when Cdc2 kinase activity was inhibited with butyrolactone-I.	butyrolactone I	107-122	cyclin dependent kinase 1	Homo sapiens	67-71	
9438384-9	1998	Butyrolactone I, an inhibitor of cdc2 kinase, inhibited increases in Cx43 phosphorylation during mitosis.	butyrolactone I	0-15	cyclin dependent kinase 1	Homo sapiens	33-37	
9042196-0	1996	Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.	butyrolactone I	21-36	cyclin dependent kinase 1	Homo sapiens	50-54	
9042196-1	1996	Butyrolactone I, which is a naturally occurring specific inhibitor of the cdc2 kinase family, showed antitumor effects on several non-small- and small-cell-lung cancer cell lines with IC50 values the order of 50 micrograms/ml on the former.	butyrolactone I	0-15	cyclin dependent kinase 1	Homo sapiens	74-78	
7574801-4	1995	Butyrolactone I inhibits both cdc2 and CDK2 kinase in the cell-free system.	butyrolactone I	0-15	cyclin dependent kinase 1	Homo sapiens	30-34	
7592534-3	1995	Most of this phosphorylation and electrophoretic mobility shift, that occurred in the brain extract incubated with ATP, were inhibited by butyrolactone I, a specific inhibitor of cdc2 kinase and cdk5.	butyrolactone I	138-153	cyclin dependent kinase 1	Homo sapiens	179-183	
8058318-1	1994	Butyrolactone I is a selective inhibitor of the cyclin-dependent kinase (cdk) family.	butyrolactone I	0-15	cyclin dependent kinase 1	Homo sapiens	73-76